Navigation Links
CIT GAP Funds Invests in STR, LLC
Date:4/22/2008

HERNDON, Va., April 22 /PRNewswire-USNewswire/ -- The Center for Innovative Technology (CIT) today announced that CIT GAP Funds is leading an investment round in Soft Tissue Regeneration, LLC (STR), a medical device company based in Earlysville, VA, that develops synthetic scaffolds to encourage tissue regeneration. CIT will invest $100,000.

Joseph W. Reilly, Chief Executive Officer of STR, said, "CIT's investment and counsel will help us begin developing the animal study protocol that will help the company reach the next stage of its development."

STR, LLC, develops breakthrough technology for soft tissue regeneration of the anterior cruciate ligament ("ACL") of the knee. The company plans to introduce its product, called the L-C Ligament(TM), to a market that averages 300,000 ACL reconstructions per year in the US, EU, Canada, Japan and Australia. The current standard of care -- primarily consisting of autografts and allografts -- have significant issues, which the L-C Ligament(TM) intends to address by stabilizing the knee and encouraging the regeneration of ligament tissue, resulting in faster, better healing and greater odds of making a full recovery.

"We agree with STR that there is a great need for a synthetic ACL, considering the many problems with the current standard of care," Peter Jobse, CIT president and CEO said. "As our population increases with more aging, active adults, that need will only expand and the marketplace will be ripe for this and other innovative medical breakthroughs."

CIT GAP Funds is a family of venture funds designed to bridge the gap between "family and friends" funding and early-stage equity investments for Virginia-based technology and life science companies. CIT GAP Funds invests in seed-stage firms with a high potential for successful commercialization, rapid growth and downstream private equity financing.

"STR is CIT GAP Funds' twenty-fifth investment," noted Tom Weithman, CIT
'/>"/>

SOURCE Center for Innovative Technology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Reduced Funds for Cancer is Cost of Iraq, Say Ex-White House Aide, Cancer Researchers
2. Pennsylvania Attorney General Corbett, American Lung Association & Others Call for New MSA Funds to Be Used for Tobacco Prevention and Cessation
3. Autism Walk Raises Awareness, Funds for Local Services
4. Harley-Davidson Womens Day Ride Raises Funds for MDAs Summer Camp Program
5. Toxic Neglect: Mutual Funds Opposing Shareholder Resolutions on Chemicals in Products Ignore Financial Risks to Shareholders
6. EPA Funds Grants for Lead Poisoning Prevention Projects in Two Wisconsin Communities
7. EPA Funds Grants for Four Lead Poisoning Prevention Projects in Michigan Communities
8. EPA Funds Grants for Lead Poisoning Prevention Projects in Two Ohio Communities
9. EPA Funds Two Grants for Lead Poisoning Prevention Projects in Chicago Communities
10. FRC Urges Rejection of Lantos Bill That Funds International Abortionists
11. Thousands of Womens Basketball Referees to Wear Pink Whistles February 8-17; Calling For a Cure Program to Raise Funds for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... -- Almost 140 people die every year in ... States. But there are several simple ways ... prevention coordinator at Cincinnati Children,s Hospital Medical Center,s ... center news release. "As families begin to ... for parents and children to go over school ...
(Date:8/1/2014)... Illinois (PRWEB) August 01, 2014 As ... across the country, Ronald E. Johnson, Jr. has been ... by AndroGel and other testosterone medications. Since the Fall ... Johnson, P.S.C. have worked diligently to investigate and prosecute ... pulmonary embolisms, and blood clots as a result of ...
(Date:8/1/2014)... August 01, 2014 Market Publishers ... reports have been added to its catalogue. ... Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services ... pharma industry drivers include, among others, increasing ageing ... hygiene. In 2015, the pharma market in India ...
(Date:8/1/2014)... HealthDay Reporter FRIDAY, Aug. 1, ... a time-honored destination for a good cut and conversation. ... be the spot to tackle an often overlooked health concern: ... partnership, the U.S. Centers for Disease Control and Prevention, together ... help of barbershop staff to both discuss and diagnose high ...
(Date:8/1/2014)... 2014 Over the past five ... innovative technologies that have enabled cosmetic dentists to ... color. Moreover, the burgeoning elderly population has stimulated ... ailments. Due to long-term use of medications, which ... demanded dental fillings, veneers and implants. As more ...
Breaking Medicine News(10 mins):Health News:Expert Offers School Bus Safety Tips 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... also available in Chinese ., , ... side effects of chemotherapy in cancer patients by stimulating ... in mice suggests., The research will appear in the ... which is published by AAAS, the nonprofit science ...
... A paper by Indiana University-Purdue University Indianapolis ... to improve identification of breast cancer tissue by ... scientific paper in the "bioinformatics and biomedical applications ... The best scientific paper award ...
... WEDNESDAY, Aug. 18 (HealthDay News) -- With their enticing cool ... the most controversial products made by the tobacco industry. ... of smokers aged 12 to 17 using menthol cigarettes, according ... Most black teenaged smokers -- and 82.7 percent of black ...
... Center in Israel have determined that the use ... outcome for patients undergoing percutaneous coronary intervention (PCI), ... appear in the September issue of Catheterization ... Wiley-Blackwell on behalf of The Society for Cardiovascular ...
... Aug. 19, 2010 A pediatric urologist at UT ... for young girls who have absent or malformed vaginas, ... Unknown causes and certain genetic disorders can cause ... other birth defects that can accompany the vaginal problems, ...
... To improve the quality of HIV care and treatment ... and monitoring of antiretroviral therapy should be adopted uniformly, according ... The work group,s study results appear in the current ... study shows how national HIV quality performance measures were developed, ...
Cached Medicine News:Health News:Ancient Chinese medicine may help chemotherapy patients 2Health News:FDA Mulling Ban on Menthol Cigarettes 2Health News:FDA Mulling Ban on Menthol Cigarettes 3Health News:FDA Mulling Ban on Menthol Cigarettes 4Health News:Drug-eluting stents confirmed safe, effective for long-term use 2Health News:Pediatric urologist performs innovative procedure for girls with rare vaginal defects 2Health News:Uniform, national measures should define HIV/AIDS care 2
(Date:7/31/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today ... June 30, 2014. Financial Results for the Six ... revenue for the quarter ended June 30, 2014 increased to ... 30, 2013 primarily due to IMBRUVICA ® (ibrutinib) net ... for the six months ended June 30, 2014 increased to ...
(Date:7/31/2014)... VIEW, Calif. , July 31, 2014 /PRNewswire/ ... today provided an update on its pipeline and ... 2014, Alexza expects to initiate a Phase 2a ... is being developed for the management of patients ... two new Staccato -based product candidates for ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek Pharmaceuticals, ... it has initiated the development of its lead molecule, ... that it has selected Quotient Clinical, The Translational Pharmaceutics ... (UK) to run its early development programs. ... Application (CTA) by the end of the third quarter ...
Breaking Medicine Technology:Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24Pharmacyclics Reports Second Quarter 2014 Results 25Pharmacyclics Reports Second Quarter 2014 Results 26Pharmacyclics Reports Second Quarter 2014 Results 27Pharmacyclics Reports Second Quarter 2014 Results 28Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4
... 4, 2011 Trinity Biotech plc (Nasdaq: TRIB ... the point-of-care and clinical laboratory markets, announced today that the ... York Micro-Cap Conference on Monday, January 10, 2011 at 1:30 ... Hyatt New York Hotel in New York City. ...
... Managed Health Care Associates, Inc. (MHA), a leading healthcare ... to announce the acquisition of Navigator, Inc., Nashville, TN. ... growing GPOs focused on servicing long term care facilities. ... home customers through its food program, supply contracts, and ...
Cached Medicine Technology:Managed Health Care Associates, Inc. (MHA) Acquires Navigator, Inc. 2Managed Health Care Associates, Inc. (MHA) Acquires Navigator, Inc. 3
... Parathyroid hormone (PTH) is synthesized ... secreted in response to decreased extracellular ... enhancing bone resorption and decreasing calcium ... into the circulation, intact PTH is ...
... the adrenal cortex and, to a lesser ... a precursor in testosterone and estrogen synthesis, ... at ~10% that of testosterone [1]. However, ... women, DHEA is an important androgen as ...
... steroid, is one of the most potent ... testosterone is secreted primarily by the testes ... peripheral conversion of androstenedione [2]. In adult ... 50% of serum testosterone is derived from ...
... Thyroxine (T4) is the primary active ... the thyroid gland [1]. T4 is synthesized ... iodide trapping by the follicular cells, (ii) ... substrate leading to formation of 3-monoiodotyrosine and ...
Medicine Products: